Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.71 USD | +0.56% | -0.15% | +12.50% |
May. 02 | Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M | MT |
May. 02 | Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19 | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The firm trades with high earnings multiples: 39.2 times its 2024 earnings per share.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.50% | 67.39M | - | ||
-7.16% | 178B | C+ | ||
-4.86% | 67.04B | A | ||
-4.28% | 47.24B | B- | ||
+10.32% | 44.62B | B- | ||
+8.14% | 42.5B | B+ | ||
+15.76% | 29.99B | B | ||
+15.53% | 25.22B | A- | ||
-5.88% | 24.14B | A- | ||
-5.38% | 23.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PDEX Stock
- Ratings Pro-Dex, Inc.